Evrofarma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	6.56	3.32	0.66	1.44	0.25
Cash & Short-Term Investments	6.56	3.32	0.66	1.44	0.25
Cash Growth	97.47%	405.94%	-54.28%	477.11%	-91.99%
Receivables	10.21	7.37	9.17	11.72	13.69
Inventory	7.07	7.11	6.52	5.56	3.07
Other Current Assets	-	-	-0	-	-
Total Current Assets	23.85	17.8	16.34	18.71	17.01
Property, Plant & Equipment	26.02	24.66	25.57	24.95	24.41
Long-Term Investments	0.01	0.22	0.01	0.06	0.04
Other Intangible Assets	0.35	0.13	0.05	0.06	0.1
Long-Term Accounts Receivable	-	0.03	0.33	0.03	0.03
Other Long-Term Assets	6.13	5.4	5.06	5.01	4.94
Total Assets	56.35	48.24	47.36	48.81	46.52
Accounts Payable	7.91	6.12	2.39	4.45	3.44
Accrued Expenses	-	-	0.5	0.45	0.87
Short-Term Debt	1.99	11.59	3.9	2.44	0.72
Current Portion of Long-Term Debt	-	-	3.08	2.71	2.5
Current Portion of Leases	0.06	0.07	0.04	0.04	0.03
Current Income Taxes Payable	0.73	0.49	0.4	0.11	-
Other Current Liabilities	-	-	2.73	2.48	2.64
Total Current Liabilities	10.7	18.26	13.04	12.67	10.2
Long-Term Debt	14.94	5.16	12.45	16.13	18.05
Long-Term Leases	0.07	0.14	0.07	0.06	0.01
Long-Term Unearned Revenue	8.78	5.73	4.43	4.69	4.42
Pension & Post-Retirement Benefits	0.09	0.08	0.07	0.05	0.05
Long-Term Deferred Tax Liabilities	1.11	1.04	1.08	1.18	1.18
Other Long-Term Liabilities	-	-0	-	-0	-
Total Liabilities	35.69	30.41	31.13	34.79	33.92
Common Stock	5.74	5.74	5.74	12.03	12.03
Additional Paid-In Capital	-	-	-	0.94	0.94
Retained Earnings	10.84	8.46	7.42	-1.49	-0.38
Comprehensive Income & Other	4.07	3.62	3.06	2.55	0.02
Shareholders' Equity	20.66	17.83	16.23	14.03	12.61
Total Liabilities & Equity	56.35	48.24	47.36	48.81	46.52
Total Debt	17.06	16.95	19.53	21.38	21.31
Net Cash (Debt)	-10.5	-13.63	-18.87	-19.94	-21.06
Net Cash Per Share	-0.77	-	-1.38	-1.46	-1.54
Filing Date Shares Outstanding	13.67	-	13.67	13.67	13.67
Total Common Shares Outstanding	13.67	-	13.67	13.67	13.67
Working Capital	13.15	-0.46	3.3	6.04	6.81
Book Value Per Share	1.51	-	1.19	1.03	0.92
Tangible Book Value	20.31	17.69	16.18	13.97	12.51
Tangible Book Value Per Share	1.49	-	1.18	1.02	0.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.